Evidence map›Paper›PMID 16900392›Full record

ReviewJournal of mammary gland biology and neoplasia2005

Benign breast diseases.

Carine Courtillot, Geneviève Plu-Bureau, Nadine Binart, Corinne Balleyguier, Brigitte Sigal-Zafrani, Vincent Goffin, Frédérique Kuttenn, Paul A Kelly, Philippe Touraine

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. The Effects ofIranian journal of pharmaceutical research : IJPR · 2018
    Article
  4. Article
  5. Effectiveness of Centchroman on Regression of Fibroadenosis and Mastalgia.Journal of clinical and diagnostic research : JCDR · 2016
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carine CourtillotDepartment of Endocrinology and Reproductive Medicine, Paris V University, GH Pitie-Salpetriere, 47/83 Bd de l'Hopital, AP-HP 75651, Paris Cedex 13, France.
Geneviève Plu-Bureau
Nadine Binart
Corinne Balleyguier
Brigitte Sigal-Zafrani
Vincent Goffin
Frédérique Kuttenn
Paul A Kelly
Philippe Touraine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benign breast diseases have always been neglected in comparison to cancer, despite the fact that there are many more patients with such diseases than patients presenting to a breast clinic for cancer. Like normal breast tissues, benign breast diseases are under a complex system of controls by both systemic hormonal and local factors. In this review, we attempt to present an overview of the latest knowledge concerning the epidemiology, classification, clinical presentation, management, and physiopathology of these disorders.

Indexed as

AdolescentAdultAnimalsBreastBreast DiseasesCystsEstradiolFemaleFibroadenomaHumansIntercellular Signaling Peptides and ProteinsMiddle AgedProlactinEstradiolIntercellular Signaling Peptides and ProteinsProlactin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.